CooperSurgical, Inc.

9 articles with CooperSurgical, Inc.

• CooperSurgical® Announces More than 11,000 Families Have Enrolled in Newborn Possibilities Program®

  1/5/2023

  CooperSurgical, a global leader in fertility and women's health, shared that more than 11,000 families have enrolled in the Newborn Possibilities Program® through their Cord Blood Registry® brand.

• CooperSurgical Acquires Embryo OptionsBest-in-class digital solution helps IVF clinics improve efficiency and educate patients about embryo management

  1/5/2021

  CooperSurgical, a leading provider of women’s health care solutions, has acquired Embryo Options, an established leader in cryo-storage software solutions for clinics and patients.

• CooperSurgical and NYU Langone Fertility Center Announce Study Data Showing Significant Increase in Ongoing Pregnancy and Live Birth Rates with Genetic Test Using Artificial Intelligence (PGTai 2.0 platform) for Patients Undergoing IVF

  10/19/2020

  Data from NYU LangoneFertility Center Study Presented at American Society of Reproductive Medicine Annual Meeting

• Teva Announces Completion of PARAGARD Divestiture to CooperSurgical

  11/2/2017

  This transaction includes Teva's manufacturing facility in Buffalo, NY, which produces PARAGARD exclusively.

• CooperSurgical, Inc. Acquires Research Instruments Limited for $51 Million

  12/31/2015

• FDA Warns CooperSurgical, Inc. About Texas Manufacturing Plant

  5/31/2013

• CooperSurgical, Inc. Launches the New MityOne&#0174 Vacuum-Assisted Delivery System

  2/28/2013

• CooperSurgical, Inc. Selects Xactly to Support Enterprise Sales

  5/1/2012

• American Medical Systems, Inc. Announces Sale of Her Option(R) Global Endometrial Ablation Product Line to CooperSurgical, Inc. for $20.5 Million

  2/17/2010